Recent Advances in Antimicrobial Nano-Drug Delivery Systems

80Citations
Citations of this article
148Readers
Mendeley users who have this article in their library.

Abstract

Infectious diseases are among the major health issues of the 21st century. The substantial use of antibiotics over the years has contributed to the dissemination of multidrug resistant bacteria. According to a recent report by the World Health Organization, antibacterial (ATB) drug resistance has been one of the biggest challenges, as well as the development of effective long-term ATBs. Since pathogens quickly adapt and evolve through several strategies, regular ATBs usually may result in temporary or noneffective treatments. Therefore, the demand for new therapies methods, such as nano-drug delivery systems (NDDS), has aroused huge interest due to its potentialities to improve the drug bioavailability and targeting efficiency, including liposomes, nanoemulsions, solid lipid nanoparticles, polymeric nanoparticles, metal nanoparticles, and others. Given the relevance of this subject, this review aims to summarize the progress of recent research in antibacterial therapeutic drugs supported by nanobiotechnological tools.

Cite

CITATION STYLE

APA

Zong, T. X., Silveira, A. P., Morais, J. V., Sampaio, M. C., Muehlmann, L. A., Zhang, J., … Liu, S. K. (2022, June 1). Recent Advances in Antimicrobial Nano-Drug Delivery Systems. Nanomaterials. MDPI. https://doi.org/10.3390/nano12111855

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free